Your browser doesn't support javascript.
loading
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes.
Hayek, Samah; Ben-Shlomo, Yatir; Dagan, Noa; Reis, Ben Y; Barda, Noam; Kepten, Eldad; Roitman, Alina; Shapira, Shachar; Yaron, Shlomit; Balicer, Ran D; Netzer, Doron; Peretz, Alon.
Afiliación
  • Hayek S; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel. samahha@clalit.org.il.
  • Ben-Shlomo Y; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
  • Dagan N; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
  • Reis BY; Software and Information Systems Engineering, Ben Gurion University, Be'er Sheva, Israel.
  • Barda N; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Kepten E; The Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute, Boston, MA, USA.
  • Roitman A; The Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute, Boston, MA, USA.
  • Shapira S; Predictive Medicine Group, Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
  • Yaron S; Harvard Medical School, Boston, MA, USA.
  • Balicer RD; Software and Information Systems Engineering, Ben Gurion University, Be'er Sheva, Israel.
  • Netzer D; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
  • Peretz A; Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
Nat Commun ; 13(1): 4480, 2022 08 02.
Article en En | MEDLINE | ID: mdl-35918340
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Israel